Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Thomas

Showing results (101-110 of 121) with videos related to

Pageof 13
Sort By:
FEBS Letters|February 13, 1995
Mechanism of resistance to U-90152S and sensitization to L-697,661 by a proline to leucine change at residue 236 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptaseN Fan, D B Evans, K B Rank, et al.
Journal of Medicinal Chemistry|February 5, 1993
Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclinesM L Nelson, B H Park, J S Andrews, et al.
Hybridoma|October 1, 1996
Mouse monoclonal antipeptide antibodies specific for cholesteryl ester transfer protein (CETP)A P Thomas, A M Smith, R I Cumming, et al.
The Journal of Investigative Dermatology|May 1, 1994
Effect of terbinafine on the pharmacokinetics of cyclosporin in humansC C Long, S A Hill, R C Thomas, et al.
Pharmaceutical Biotechnology|October 7, 1998
Discovery and development of the BHAP nonnucleoside reverse transcriptase inhibitor delavirdine mesylateW J Adams, P A Aristoff, R K Jensen, et al.
Journal of Medicinal Chemistry|May 14, 1993
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidateD L Romero, R A Morge, M J Genin, et al.
Biochemistry|July 30, 1996
A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradationN Fan, K B Rank, D E Slade, et al.
Experientia|January 15, 1994
Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitorI W Althaus, J J Chou, A J Gonzales, et al.
Biochemistry|July 6, 1993
Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204EI W Althaus, J J Chou, A J Gonzales, et al.
Biochemical Pharmacology|June 1, 1994
Kinetic studies with the non-nucleoside human immunodeficiency virus type-1 reverse transcriptase inhibitor U-90152EI W Althaus, J J Chou, A J Gonzales, et al.
Pageof 13

Showing results (101-110 of 121) with videos related to

Sort By:
Pageof 13
FEBS Letters|February 13, 1995
Mechanism of resistance to U-90152S and sensitization to L-697,661 by a proline to leucine change at residue 236 of human immunodeficiency virus type 1 (HIV-1) reverse transcriptaseN Fan, D B Evans, K B Rank, et al.
Journal of Medicinal Chemistry|February 5, 1993
Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclinesM L Nelson, B H Park, J S Andrews, et al.
Hybridoma|October 1, 1996
Mouse monoclonal antipeptide antibodies specific for cholesteryl ester transfer protein (CETP)A P Thomas, A M Smith, R I Cumming, et al.
The Journal of Investigative Dermatology|May 1, 1994
Effect of terbinafine on the pharmacokinetics of cyclosporin in humansC C Long, S A Hill, R C Thomas, et al.
Pharmaceutical Biotechnology|October 7, 1998
Discovery and development of the BHAP nonnucleoside reverse transcriptase inhibitor delavirdine mesylateW J Adams, P A Aristoff, R K Jensen, et al.
Journal of Medicinal Chemistry|May 14, 1993
Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamido-1H-indol-2-yl)-carbonyl]-4-[3- [(1-methylethyl)amino]-pyridinyl]piperazine monomethanesulfonate (U-90152S), a second-generation clinical candidateD L Romero, R A Morge, M J Genin, et al.
Biochemistry|July 30, 1996
A drug resistance mutation in the inhibitor binding pocket of human immunodeficiency virus type 1 reverse transcriptase impairs DNA synthesis and RNA degradationN Fan, K B Rank, D E Slade, et al.
Experientia|January 15, 1994
Steady-state kinetic studies with the polysulfonate U-9843, an HIV reverse transcriptase inhibitorI W Althaus, J J Chou, A J Gonzales, et al.
Biochemistry|July 6, 1993
Kinetic studies with the non-nucleoside HIV-1 reverse transcriptase inhibitor U-88204EI W Althaus, J J Chou, A J Gonzales, et al.
Biochemical Pharmacology|June 1, 1994
Kinetic studies with the non-nucleoside human immunodeficiency virus type-1 reverse transcriptase inhibitor U-90152EI W Althaus, J J Chou, A J Gonzales, et al.
Pageof 13